跳至主要内容
临床试验/CTRI/2022/10/046263
CTRI/2022/10/046263尚未招募3 期

Comparative evaluation of Platelet Rich Plasma (PRP) versus Triamcinolone Acetonide and Hyaluronidase combination in the treatment of Oral Submucous Fibrosis.

Dr Ajay Kumar0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient above the age of 17 years to 65 years.
  • 2. Patients clinically diagnosed with grade II and III OSMF patients (Clinical staging by Laiââ?¬•s, 1995).
  • 3. Patients who had not undergone any treatment for OSMF in the past 1 year.
  • 4. Cooperative patients.
  • 5. Patients without any systemic illness.
  • 6. Patients who were willing to quit gutkha, arecanut and/or tobacco chewing habit.
  • 7. Patients who agreed for regular follow ups.

排除标准

  • 1. OSMF patients with coexisting uncontrolled systemic illness.
  • 2. Patients who had received previous treatment.
  • 3. Patients with other mucosal/potentially medically disorders such as leukoplakia or lichen planus.
  • 4. Patients with history of drug allergy.
  • 5. Pregnant or breastfeeding women.
  • 6. Patients not consenting to participate.

研究者

发起方
Dr Ajay Kumar

相似试验